Latest News
CorMedix Inc.
- CorMedix's (CRMD) Buy Rating Reaffirmed at Needham & Company LLC
- Cormedix Rezzayo label expansion under FDA review (CRMD:NASDAQ)
- FDA accepts CorMedix filing for rezafungin fungal prophylaxis
- Cormedix Announces FDA Acceptance for Priority Review of
- CorMedix (CRMD) Slips 2.68% to $7.26 as Shares Test Lower End of Recent Range - Bearish Sentiment
- CorMedix (NASDAQ: CRMD) Strengthens Its Commercial Growth Story
- With EPS Growth And More, CorMedix (NASDAQ:CRMD) Makes An Interesting Case
- CorMedix Inc (NASDAQ:CRMD) Stock Now Rated "Moderate Buy" by Wall Street Analysts
- 150,656 Shares in CorMedix Inc $CRMD Acquired by Bank of America Corp DE
- Form 4 CorMedix Inc For: 27 September By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →